The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
申请公布号
WO2009029384(A2)
申请公布日期
2009.03.05
申请号
WO2008US71881
申请日期
2008.08.01
申请人
BRISTOL-MYERS SQUIBB COMPANY;MARTIN, SCOTT W.;BERGSTROM, CARL P.;GENTLES, ROBERT G.;YEUNG, KAP-SUN
发明人
MARTIN, SCOTT W.;BERGSTROM, CARL P.;GENTLES, ROBERT G.;YEUNG, KAP-SUN
